Biblio

Export 3173 results:
Author Title Type [ Year(Desc)]
2015
K. Nho, Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., Callahan, C. M., Hendrie, H. C., Niculescu, A. B., and Saykin, A. J., “Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults.”, J Alzheimers Dis, 2015.
C. Balducci, Paladini, A., Micotti, E., Tolomeo, D., La Vitola, P., Grigoli, E., Richardson, J. C., and Forloni, G., “The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.”, J Alzheimers Dis, 2015.
E. Coart, Barrado, L. García, Duits, F. H., Scheltens, P., van der Flier, W. M., Teunissen, C. E., van der Vies, S. M., and Burzykowski, T., “Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
C. Conejero-Goldberg, Hyde, T. M., Chen, S., Herman, M. M., Kleinman, J. E., Davies, P., and Goldberg, T. E., “Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.”, J Alzheimers Dis, 2015.
L. Calderón-Garcidueñas, Mora-Tiscareño, A., Sánchez, G. Melo, Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., and Jewells, V., “A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.”, J Alzheimers Dis, 2015.
D. N. Kiosses, Rosenberg, P. B., McGovern, A., Fonzetti, P., Zaydens, H., and Alexopoulos, G. S., “Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia.”, J Alzheimers Dis, vol. 48, no. 2, pp. 453-62, 2015.
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., “Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.”, J Alzheimers Dis, 2015.
Q. Zhao, Roberts, R. O., Ding, D., Cha, R., Guo, Q., Meng, H., Luo, J., Machulda, M. M., V Pankratz, S., Wang, B., Christianson, T. J. H., Aakre, J. A., Knopman, D. S., Boeve, B. F., Hong, Z., and Petersen, R. C., “Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 47, no. 1, pp. 167-76, 2015.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., “Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
G. J. Brewer, “Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
G. Giaccone, “The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.”, J Alzheimers Dis, 2015.
H. H. Hansen, Fabricius, K., Barkholt, P., Niehoff, M. L., Morley, J. E., Jelsing, J., Pyke, C., Knudsen, L. Bjerre, Farr, S. A., and Vrang, N., “The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
J. Thomas- Ric Keeney, Ibrahimi, S., and Zhao, L., “Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.”, J Alzheimers Dis, vol. 48, no. 2, pp. 411-24, 2015.
S. Meier, Bell, M., Lyons, D. N., Ingram, A., Chen, J., Gensel, J. C., Zhu, H., Nelson, P. T., and Abisambra, J. F., “Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.”, J Alzheimers Dis, 2015.
E. Moyse, Bastin, C., Salmon, E., and Brédart, S., “Impairment of Age Estimation from Faces in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., “Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
R. Migliaccio, Agosta, F., Possin, K. L., Canu, E., Filippi, M., Rabinovici, G. D., Rosen, H. J., Miller, B. L., and Gorno-Tempini, M. Luisa, “Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, 2015.
L. S. Pimentel, Allard, S., Carmo, S. Do, Weinreb, O., Danik, M., Hanzel, C. E., Youdim, M. B., and A Cuello, C., “The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 2, pp. 373-83, 2015.
M. A. Bradley-Whitman, Abner, E., Lynn, B. C., and Lovell, M. A., “A Novel Plasma Based Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 3, pp. 761-71, 2015.
S. Oleson and Murphy, C., “Olfactory Dysfunction in ApoE ε4/4 Homozygotes with Alzheimer's Disease.”, J Alzheimers Dis, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
K. E. Pike, Zeneli, A., Ong, B., Price, S., and Kinsella, G. J., “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
E. C. Edmonds, Delano-Wood, L., Galasko, D. R., Salmon, D. P., and Bondi, M. W., “Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 231-42, 2015.
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., and O'Brien, T. J., “Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 4, pp. 965-75, 2015.

Pages